A randomized multicenter study: safety and efficacy of mini-pool intravenous immunoglobulin versus standard immunoglobulin in children aged 1-18 years with immune thrombocytopenia

Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs

(2016) Eric M. Ammann et al.   AMERICAN JOURNAL OF HEMATOLOGY

IVIG in autoimmune disease — Potential next generation biologics

(2016) Adrian W. Zuercher et al.   AUTOIMMUNITY REVIEWS

Comparison between IV immune globulin (IVIG) and anti-D globulin for treatment of immune thrombocytopenia: a randomized open-label study

(2016) Aziz Eghbali et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Multicenter Cohort Study Comparing U.S. Management of Inpatient Pediatric Immune Thrombocytopenia to Current Treatment Guidelines

(2016) Char M. Witmer et al.   PEDIATRIC BLOOD & CANCER

Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases

(2015) Zeping Zhou et al.   AUTOIMMUNITY

Treatment of Pediatric Primary Immune Thrombocytopenia With Thrombopoietin Receptor Agonists

(2015) Thomas Kühne   SEMINARS IN HEMATOLOGY

Possible mechanisms for intravenous immunoglobulin-associated hemolysis: clues obtained from review of clinical case reports

(2015) Ruth Padmore   TRANSFUSION

Complementary use of passive surveillance and Mini-Sentinel to better characterize hemolysis after immune globulin

(2015) Scott Winiecki et al.   TRANSFUSION

Minipool Caprylic Acid Fractionation of Plasma Using Disposable Equipment: A Practical Method to Enhance Immunoglobulin Supply in Developing Countries

(2015) Magdy El-Ekiaby et al.   PLoS Neglected Tropical Diseases

Outpatient Management of Patients with Immune Thrombocytopenia (ITP) by Hematologists 1995-2014

(2015) Rudolf Weide et al.   Oncology Research and Treatment

Quantifying the thrombogenic potential of human plasma-derived immunoglobulin products

(2014) W.A. Germishuizen et al.   BIOLOGICALS

Clinical practice: immune thrombocytopenia in paediatrics

(2014) Veerle Labarque et al.   EUROPEAN JOURNAL OF PEDIATRICS

Intravenous immunoglobulin-associated thrombosis: is it such a rare event? Report of a pediatric case and of the Quebec Hemovigilance System

(2014) Joy Benadiba et al.   TRANSFUSION

Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe

(2014) Jacqueline Kerr et al.   Frontiers in Immunology

The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

(2011) C. Neunert et al.   BLOOD

Efficacy and safety of Hizentra® in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy

(2011) S. Jolles et al.   CLINICAL IMMUNOLOGY

Diagnosis and management of chronic ITP: comments from an ICIS expert group

(2010) John David Grainger et al.   ANNALS OF HEMATOLOGY

Intracranial Hemorrhage in Acute and Chronic Childhood Immune Thrombocytopenic Purpura over a Ten-Year Period: An Egyptian Multicenter Study

(2009) Mohsen Elalfy et al.   ACTA HAEMATOLOGICA

Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases

(2009) B. Psaila et al.   BLOOD

Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS)

(2009) Rienk Tamminga et al.   BRITISH JOURNAL OF HAEMATOLOGY

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD